Valuation: Tactile Systems Technology, Inc.

Market Cap 692M 605M 558M 516M 978M 66B 995M 6.67B 2.62B 32.51B 2.6B 2.54B 112B P/E 2026 *
27.4x
P/E 2027 * 20.2x
Enterprise Value 692M 605M 558M 516M 978M 66B 995M 6.67B 2.62B 32.51B 2.6B 2.54B 112B EV / Sales 2026 *
1.9x
EV / Sales 2027 * 1.74x
Free-Float
97.69%
Yield 2026 *
-
Yield 2027 * -
1 day-2.74%
1 week-6.37%
Current month+0.20%
1 month+14.90%
3 months+27.36%
6 months-0.10%
Current year+2.90%
1 week 29.22
Extreme 29.225
32.44
1 month 25.24
Extreme 25.24
32.44
Current year 20.53
Extreme 20.53
37.77
1 year 9.42
Extreme 9.415
37.77
3 years 8.61
Extreme 8.6098
37.77
5 years 6.28
Extreme 6.28
51
10 years 6.28
Extreme 6.28
76.63
Manager TitleAgeSince
Chief Executive Officer 60 01/07/2024
Director of Finance/CFO 51 20/03/2023
Chief Tech/Sci/R&D Officer - 01/04/2023
Director TitleAgeSince
Chairman 66 01/09/2015
Director/Board Member 67 20/09/2017
Director/Board Member 60 01/01/2021
Date Insider Type Main position Quantity % Market Cap.
05-11Sell

Chief Financial Officer

-4,631 0.0204%
05-06Free

Director

6,521 0.0287%
05-06Free

Chairman

6,521 0.0287%
Change 5-day change 1-year change 3-year change Capi.($)
-2.74%-6.37%+190.84%+22.60% 692M
-0.06%-0.19%+30.24%-2.95% 12.51B
-2.70%-5.50%+56.06%+31.24% 6B
+2.16%-0.14%+7.62%+14.59% 5.73B
-0.20%-1.77% - - 4.23B
+3.82%+5.08%-30.34%+15.21% 4.1B
+1.84%-0.61%-25.08%-26.66% 3.75B
-4.92%-5.11%-10.97%-60.80% 2B
+2.48%+3.12%+20.44%+266.67% 1.89B
-0.98%+1.78%+56.43%-5.02% 1.57B
Average -0.18%-0.03%+32.80%+28.32% 4.25B
Weighted average by Cap. +0.13%-0.35%+20.31%+15.33%

Financials

2026 *2027 *
Net sales 365M 319M 294M 272M 516M 34.79B 524M 3.52B 1.38B 17.14B 1.37B 1.34B 58.93B 398M 348M 321M 296M 562M 37.92B 572M 3.83B 1.5B 18.68B 1.49B 1.46B 64.21B
Net income 25.33M 22.16M 20.44M 18.87M 35.81M 2.42B 36.42M 244M 95.89M 1.19B 95.1M 93.03M 4.09B 34.55M 30.22M 27.88M 25.75M 48.85M 3.3B 49.67M 333M 131M 1.62B 130M 127M 5.58B
Net Debt - -
Logo Tactile Systems Technology, Inc.
Tactile Systems Technology, Inc., doing business as Tactile Medical, is a medical technology company that manufactures and distributes medical devices for the treatment of patients with chronic diseases at home. The Company's areas of therapeutic focus are vascular disease, oncology and providing airway clearance therapy for those suffering from chronic respiratory conditions. It is developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease. It markets Flexitouch Plus and Entre Plus systems as at-home therapies for the treatment of lymphedema and chronic venous insufficiency. It markets AffloVest as an at-home therapy intended to promote airway clearance. Its Flexitouch Plus system is a fully automated, programmable, advanced pneumatic compression device. It also offers Kylee, a free mobile application that helps patients learn about lymphedema.
Employees
1,086
Date Price Change Volume
10/07/26 $29.84 -2.74% 209,004
09/07/26 $30.68 +2.33% 120,268
08/07/26 $29.98 -4.80% 199,845
07/07/26 $31.49 -1.19% 260,377
06/07/26 $31.87 +1.66% 185,312
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
30.68USD
Average target price
39.50USD
Spread / Average Target
+28.75%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TCMD Stock